Concepedia

Long-term Immunogenicity

Long-Term Immunogenicity is the sustained ability of a vaccine candidate to elicit and maintain a specific immune response over an extended period, as measured by the persistence of immunological markers such as antibodies or memory cells following initial administration.

231

Publications

12K

Citations

1.9K

Authors

601

Institutions

Publications per year

2017–2026

80

Parents

Publications

231

Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men

Stephen C. Hadler, Donald P. Francis, James E. Maynard et al. · New England Journal of Medicine · 1986 · 618 citations

, , +17

Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality

Michael J. Mina, C. Jessica E. Metcalf, Rik L. de Swart et al. · Science · 2015 · 419 citations · Full text

, , +17

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study

Alessandro Zanetti, Andrea Mariano, Luisa Romanò et al. · The Lancet · 2005 · 369 citations

, , +15

Survival of long-lived plasma cells is independent of antigen [In Process Citation]

Rudolf A. Manz · International Immunology · 1998 · 345 citations

, , +14

Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐up

Irja Davidkin, Sari Jokinen, Mia Broman et al. · The Journal of Infectious Diseases · 2008 · 326 citations · Full text

, , +16

1–5 of 231

Authors

1.9K

  1. PV
    Pierre Van Damme

    University of Antwerp, Belgium

    13 publications · 941 citations

    12

    h-index

  2. KV
    Koen Van Herck

    University of Antwerp, Belgium

    9 publications · 498 citations

    9

    h-index

  3. ST
    Silvio Tafuri

    University of Bari Aldo Moro, Italy

    8 publications · 242 citations

    8

    h-index

  4. FP
    Francesco Paolo Bianchi

    University of Bari Aldo Moro, Italy

    8 publications · 242 citations

    8

    h-index

  5. PS
    Pasquale Stefanizzi

    University of Bari Aldo Moro, Italy

    7 publications · 206 citations

    7

    h-index

1–5 of 1.9K

Institutions

601

  1. GlaxoSmithKline (Belgium)

    Wavre, Belgium

    18 h-index

    62 publications

    2.4K citations

  2. University of Antwerp

    Antwerp, Belgium

    12 h-index

    33 publications

    2.6K citations

  3. University of Bari Aldo Moro

    Bari, Italy

    11 h-index

    55 publications

    2.1K citations

  4. GlaxoSmithKline (India)

    Mumbai, India

    8 h-index

    9 publications

    253 citations

  5. GlaxoSmithKline (United States)

    Philadelphia, United States

    7 h-index

    12 publications

    552 citations

  6. Infectious Diseases Institute

    Kampala, Uganda

    7 h-index

    12 publications

    717 citations

  7. University Medical Center Hamburg-Eppendorf

    Hamburg, Germany

    6 h-index

    11 publications

    317 citations

  8. Universität Hamburg

    Hamburg, Germany

    6 h-index

    12 publications

    341 citations

1–8 of 601

Venues

  1. Vaccine

    50 publications · 2.8K citations

    30

    h-index

  2. Human Vaccines & Immunotherapeutics

    HV&I · 15 publications · 594 citations

    13

    h-index

  3. The Journal of Infectious Diseases

    JID · 12 publications · 1.1K citations

    12

    h-index

  4. PubMed

    Repository · 12 publications · 356 citations

    11

    h-index

  5. The Pediatric Infectious Disease Journal

    PIDJ · 10 publications · 301 citations

    10

    h-index

1–5